EMBRACING THE FUTURE OF CLINICAL RESEARCH: UNLOCKING THE BENEFITS OF DECENTRALIZED TRIALS
*Koraganji Yamini and Kusuma Tiruveedhi
ABSTRACT
Decentralized clinical trials (DCTs) have the potential to improve accessibility, diversity, and retention in clinical trials by moving trial activities to participants homes and local surroundings. The key opportunities of decentralized trials include applying a lower participation burden, allowing underserved groups to share in Clinical trials, and getting data from the real world. In addition, regulators indicated that data collected in DCTs are expected to be more representative of the real world. The epidemic has impelled regulators to take a position on the perpetration of decentralized essentials in clinical trials, and several European national competent authorities (NCAs) have lately expressed interest in DCTs, issuing instructions and conducting DCT experimental trials To facilitate future learning, hybrid clinical trials with both on-site and decentralized elements are proposed by the respondents.
Keywords: Decentralized clinical trials (DCTs), Accessibility, Diversity, Retention, Real-world data.
[Full Text Article]
[Download Certificate]